1. A method of applying an image to an object comprising:
(a) positioning a sublimation transfer medium having a sublimation ink image on the object;
(b) positioning a microwave susceptor comprising of a sheet of dielectric material coated with a metal of thickness that absorbs microwave frequency radiation over the sublimation transfer medium;
(c) clamping the transfer medium and the microwave susceptor to the obiect with a clamp, wherein the object and the clamp are not electrically conductive; and
(d) subjecting the microwave susceptor to microwave frequency radiation.
2. A method as recited in claim 1 wherein the object includes a coating with a material receptive to sublimation ink.
3. A method as recited in claim 2 where the coating includes a polymer.
4. A method as recited in claim 3 where the coating is polyester-based.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
What is claimed is:
1. An aqueous control solution, comprising a predetermined amount of an analyte, a hydrophobic reference dye and a surfactant.
2. The solution of claim 1, further comprising an indicator dye.
3. The solution of claim 2, wherein the indicator dye is selected from the group consisting of sulforhodamine B, rose bengal, amaranth and 8-(anilino)-1-naphthalenesulfonate (ANS).
4. The solution of claim 2, wherein the indicator dye or reaction product thereof and the hydrophobic reference dye absorb light at different wavelengths.
5. The solution of claim 1, wherein the hydrophobic reference dye absorbs infrared light.
6. The solution of claim 5, wherein the hydrophobic reference dye is selected from the group consisting of C62H96N6SbF6 (ADS905AM), C62H92Cl2N6O8 (SDA8080), and C62H92N6SbF6 (SDA5324).
7. The solution of claim 1, wherein the analyte is selected from the group consisting of glucose, cholesterol, tryglycerides, fructosamine, amino acids, electrolytes, urea, uric acid, lactate, ketones, hemoglobin, glycosylated hemoglobin, microalbumin, creatinine, an antigen, a hapten, an antibody, and a drug or drug metabolite.
8. The solution of claim 7, wherein the analyte is glucose.
9. The solution of claim 1, wherein the surfactant is selected from the group consisting of sodium alkyl sulfate, bile acid surfactants, sulfobetaines, alkylglucosides, salts thereof and mixtures thereof.
10. The solution of claim 1, wherein the surfactant is an anionic surfactant.
11. The solution of claim 10, wherein the anionic surfactant is selected from the group consisting of sodium dodecyl sulfate, ammonium perfluoralkyl carboxylate, sodium lauroyl myristoyl lactylate, glycocholic acid, cholic acid, taurocholic acid, deoxycholic acid, glycodeoxycholic acid, taurodeoxycholic acid, amine alkylbenzene sulfonate, sodium dioctylsulfosuccinate, sodium olefin sulfonate, sodium polyoxyethylene(1) lauryl sulfate, salts thereof, and mixtures thereof.
12. The solution of claim 1, wherein the surfactant is a non-ionic surfactant.
13. The solution of claim 12, wherein the non-ionic surfactant is selected from the group consisting of dodecyl–D-maltoside, N,N-bis(3-D-glucon-amidopropyl) cholamide, polyoxypropylene-polyoxyethylene block copolymer, N-tetradecyl–D-maltoside, daconyl-N-methyl-glucamide, hexyl–D-glucopyranoside, heptyl–D-glucopyranoside, octyl–D-glucopyranoside, nonyl–D-glucopyranoside, decyl–D-glucopyranoside, dodecyl–D-glucopyranoside, octyl–D-thioglucopyranoside, polyethylene glycol ester of stearic acid, ethoxylated cocomonoglyceride, octyphenoxypoly (ethyleneoxy) ethanol, ethoxylated octylphenol, polyoxyethylene alkyl ethers, and mixtures thereof.
14. The solution of claim 1, wherein the surfactant is amphoteric.
15. The solution of claim 14, wherein the amphoteric surfactant is selected from the group consisting of N-dodecyl-N,N-dimethylglycine, lauramidopropyl betaine, N-tetradecyl-N,N-dimethyl-3-ammonio-1-propanesulfonate, N-dodecyl-N,N-dimethyl-3-ammonio-1-propanesulfonate, cocoamidopropylbetaine, cocoamidosulfobetaine, N-octyl-N,N-dimethyl-3-ammonio-1-propanesulfonate, N-tetradecyl-N,N-dimethyl-3-ammonio-1-propanesulfonate, salts thereof, and mixtures thereof.
16. The solution of claim 1, wherein the surfactant is a cationic surfactant.
17. The solution of claim 16, wherein the cationic surfactant is selected from the group consisting of coco hydroxyethyl imidazoline, lauryltrimethylammonium chloride, decyltrimethylammonium bromide, octyltrimethylammonium bromide, cetyl trimethyl ammonium bromide, salts thereof, and mixtures thereof.
18. The solution of claim 1, further comprising an antifoaming agent.
19. The solution of claim 18, wherein the antifoaming agent is selected from the group consisting of dimethyl siloxane, methyl cellulose, a hydrogenated tallow glyceride, a silicone polymer and mixtures thereof.
20. The solution of claim 1, further comprising a preservative.
21. The solution of claim 20, wherein the preservative is selected from the group consisting of diazolidinyl urea, sodium benzoate, potassium benzoate, benzalkonium chloride, chlorhexidine, imidazolidinyl urea, 5-chloro-2-methyl-4-isothiazolin-3-one, 2-methyl-4-isothiazolin-3-one, and mixtures thereof.
22. The solution of claim 1, further comprising a chelator.
23. The solution of claim 22, wherein the chelator is selected from the group consisting of ethylenediaminetetraacetic acid, citric acid, salts thereof, and hydrates thereof.
24. The solution of claim 1, further comprising a buffer.
25. The solution of claim 24, wherein the buffer is selected from the group consisting of a citrate buffer, an imidazole buffer, and a N-2-hydroxyethyl piperazine-N-2-ethanesulfonic acid buffer.
26. The solution of claim 1, further comprising a viscosity enhancer.
27. The solution of claim 26, wherein the viscosity enhancer is one or more compounds selected from the group consisting of glycerol, polyvinylpyrrolidone, starch, and combinations thereof.
28. An aqueous control solution, comprising a predetermined amount of glucose, C62H96N6SbF6 (ADS905AM), sodium dodecyl sulfate, and an indicator dye selected from the group consisting of sulforhodamine B and rose bengal.
29. The solution of claim 28, further comprising a preservative.
30. The solution of claim 29, wherein the preservative is selected from the group consisting of diazolidinyl urea, sodium benzoate, potassium benzoate, benzalkonium chloride, chlorhexidine, imidazolidinyl urea, 5-chloro-2-methyl-4-isothiazolinone, 2-methyl-4-isothiazoline-3-one and mixtures thereof.
31. The solution of claim 30, wherein the preservative is diazolidinyl urea or a mixture of 5-chloro-2-methyl-4-isothiazolin-one and 2-methyl-4-isothiazoline-3-one.
32. The solution of claim 28, further comprising a buffer.
33. The solution of claim 32, wherein the buffer is selected from the group consisting of a citrate buffer, an imidazole buffer and a N-2-hydroxyethyl piperazine-N-2-ethanesulfonic acid buffer.
34. The solution of claim 28, further comprising a viscosity enhancer.
35. The solution of claim 34, wherein the viscosity enhancer is glycerol, polyvinylpyrrolidone or a combination thereof.
36. The solution of claim 28, further comprising:
a) a citrate buffer or a N-2-hydroxyethyl piperazine-N-2-ethanesulfonic acid buffer;
b) glycerol, polyvinylpyrrolidone, or a combination thereof; and
c) diazolidinyl urea, or a combination of 5-chloro-2-methyl-4-isothiazolin-one and 2-methyl-4-isothiazoline-3-one.